Rendering

Component: (Network and Table)
Network
001000 - Statement - CONSOLIDATED BALANCE SHEETS
(http://accesspharma.com/role/ConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
CONSOLIDATED BALANCE SHEETS (Parenthetical) [Abstract]Period [Axis]
2011-12-31
2010-12-31
2009-12-31
CONSOLIDATED BALANCE SHEETS (Parenthetical) [Abstract]
 
 
 
Current assets
 
 
 
Cash and cash equivalents
2,460,000  
7,033,000  
607,000  
Receivables
333,000  
1,018,000  
 
Inventory
151,000  
 
 
Restricted cash
330,000  
 
 
Prepaid expenses and other current assets
39,000  
70,000  
 
Total current assets
3,313,000  
 
8,121,000  
 
 
 
Property and equipment, net
51,000  
32,000  
 
Patents, net
362,000  
574,000  
 
Other assets
59,000  
44,000  
 
Total assets
3,785,000  
 
8,771,000  
 
 
 
LIABILITIES AND STOCKHOLDERS' DEFICIT
 
 
 
Current liabilities
 
 
 
Accounts payable
1,713,000  
2,984,000  
 
Accrued expenses
857,000  
857,000  
 
Dividends payable
6,487,000  
4,443,000  
 
Accrued interest payable
98,000  
126,000  
 
Debt, current portion
2,750,000  
5,500,000  
 
Current portion of deferred revenue
285,000  
347,000  
 
Total current liabilities
12,190,000  
 
14,257,000  
 
 
 
Derivative liability - warrants
1,507,000  
5,087,000  
 
Derivative liability - preferred stock
4,430,000  
5,840,000  
 
Long-term deferred revenue
3,264,000  
4,382,000  
 
Total liabilities
21,391,000  
 
29,566,000  
 
 
 
Commitments and contingencies
xsi:nil 
xsi:nil 
 
Stockholders' deficit
 
 
 
Convertible preferred stock - $.01 par value; authorized 2,000,000 shares; 2,938.3617 issued at December 31, 2011; 2,978.3617 issued at December 31, 2010
 
 
 
Common stock - $.01 par value; authorized 100,000,000 shares; issued 23,890,787 at December 31, 2011; issued 19,115,010 at December 31, 2010
239,000  
191,000  
 
Additional paid-in capital
237,600,000  
230,153,000  
 
Treasury stock, at cost - 163 shares
(4,000) 
(4,000) 
 
Accumulated deficit
(255,441,000) 
(251,135,000) 
 
Total stockholders' deficit
(17,606,000) 
 
(20,795,000) 
 
 
 
Total liabilities and stockholders' deficit
3,785,000  
 
8,771,000